Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

ATOS US

Home Stock Screener Document Search Charting Watchlists Recent Filings

Atossa Therapeutics, Inc.(ATOS US)

$1.96+0.021.03%Ext:$1.81-0.157.81%(Market Closed · 00:55:17 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

ATOS US

Home Stock Screener Document Search Charting Watchlists Recent Filings

Atossa Therapeutics, Inc.(ATOS US)

$1.96+0.021.03%Ext:$1.81-0.157.81%(Market Closed · 00:55:17 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Financials & Metrics

Financials Charting Short Interest Employees

Financials & Metrics

Financials Charting Short Interest Employees

Chronological SEC Filings

Chronological SEC Filings

Non-Ownership Filings(433)

8-KResults of Operations and Financial Condition10 Nov
10-QQ3ended 30 Sept 202610 Nov
8-KEntry into a Material Definitive Agreement9 Oct
8-KOther Events29 Sep
8-KRegulation FD Disclosure18 Sep
8-KResults of Operations and Financial Condition7 Aug
10-QQ2ended 30 Jun 20267 Aug
424B5Prospectus filing (Rule 424(b)(5))12 Jun
8-KEntry into a Material Definitive Agreement11 Jun
8-KFinancial Statements and Exhibits8 May
10-QQ1ended 31 Mar 20268 May
8-KSubmission of Matters to a Vote of Security Holders8 May
8-KOther Events16 Apr
ARSAnnual report to security holders30 Mar
DEF 14ADefinitive proxy statement30 Mar
10-KFY 2025ended 31 Dec 202525 Mar
8-KFinancial Statements and Exhibits25 Mar
PRE 14APreliminary proxy statement20 Mar
8-KEntry into a Material Definitive Agreement20 Feb
424B5Prospectus filing (Rule 424(b)(5))20 Feb

Ownership Filings(190)

Form 4Steinhart Richard I14 May
Form 4Chen Shu-Chih14 May
Form 4Remmel H. Lawrence14 May
Form 4Finn Jonathan14 May
Form 4Galli Stephen J14 May
Form 4Cigler Tessa14 May
Form 4QUAY STEVEN C31 Mar
Form 4Daniel Mark James30 Mar
Form 4/AQUAY STEVEN C30 Jan
Form 4QUAY STEVEN C22 Jan
Form 3Daniel Mark James21 Oct 2025
Form 4Daniel Mark James21 Oct 2025
SC 13G/AATOSSA THERAPEUTICS, INC.29 Jul 2025
SC 13G/AATOSSA THERAPEUTICS, INC.16 Jul 2025
Form 4QUAY STEVEN C22 May 2025
Form 4Rees Heather16 May 2025
Form 4Remmel H. Lawrence16 May 2025
Form 4Cigler Tessa16 May 2025
Form 4Steinhart Richard I16 May 2025
Form 4Finn Jonathan16 May 2025

Non-Ownership Filings(433)

8-KResults of Operations and Financial Condition10 Nov
10-QQ3ended 30 Sept 202610 Nov
8-KEntry into a Material Definitive Agreement9 Oct
8-KOther Events29 Sep
8-KRegulation FD Disclosure18 Sep
8-KResults of Operations and Financial Condition7 Aug
10-QQ2ended 30 Jun 20267 Aug
424B5Prospectus filing (Rule 424(b)(5))12 Jun
8-KEntry into a Material Definitive Agreement11 Jun
8-KFinancial Statements and Exhibits8 May
10-QQ1ended 31 Mar 20268 May
8-KSubmission of Matters to a Vote of Security Holders8 May
8-KOther Events16 Apr
ARSAnnual report to security holders30 Mar
DEF 14ADefinitive proxy statement30 Mar
10-KFY 2025ended 31 Dec 202525 Mar
8-KFinancial Statements and Exhibits25 Mar
PRE 14APreliminary proxy statement20 Mar
8-KEntry into a Material Definitive Agreement20 Feb
424B5Prospectus filing (Rule 424(b)(5))20 Feb

Ownership Filings(190)

Form 4Steinhart Richard I14 May
Form 4Chen Shu-Chih14 May
Form 4Remmel H. Lawrence14 May
Form 4Finn Jonathan14 May
Form 4Galli Stephen J14 May
Form 4Cigler Tessa14 May
Form 4QUAY STEVEN C31 Mar
Form 4Daniel Mark James30 Mar
Form 4/AQUAY STEVEN C30 Jan
Form 4QUAY STEVEN C22 Jan
Form 3Daniel Mark James21 Oct 2025
Form 4Daniel Mark James21 Oct 2025
SC 13G/AATOSSA THERAPEUTICS, INC.29 Jul 2025
SC 13G/AATOSSA THERAPEUTICS, INC.16 Jul 2025
Form 4QUAY STEVEN C22 May 2025
Form 4Rees Heather16 May 2025
Form 4Remmel H. Lawrence16 May 2025
Form 4Cigler Tessa16 May 2025
Form 4Steinhart Richard I16 May 2025
Form 4Finn Jonathan16 May 2025